Zurueck zur Suche

Reporte zur Charge 34YN4

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

26Reporte angezeigt
0Todesfaelle
3Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MI 7 PA 3 NJ 3 MN 3 IA 3 OH 2 MD 1 NY 1 DE 1

VAERS 2287195

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge 34YN4

kritisch
Staat
MI
Alter
90,0
Geschlecht
M
Eingang
20.05.2022
Impfdatum
06.11.2021
Beginn
12.05.2022
Tage bis Beginn
187,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Acute respiratory failure Blood creatinine increased COVID-19 Creatinine renal clearance decreased Pancytopenia White blood cell count decreased

Symptomtext

Admission Date: 5/12/2022 Discharge Date: 5/14/2022 HOSPITAL PROBLEMS 1. AHRF secondary to Covid-19 infection 2. CKD3b 3. Pancytopenia 4. OSA 5. CAD s/p CABG 6. COPD 7. Gout 8. Barretts esophagus HOSPITAL COURSE: Patient is a 91 y.o. male who was admitted to hospital with AHRF secondary to Covid-19 infection. AHRF/Covid-19 infection: Patient required 2L NC on admission to maintain saturations. Was started on 10 day course of decadron. Did not start Remdesivir due to low CrCl. Patient improved quickly, and was weaned to room air. Observed for 24hrs to ensure no further desaturations. None noted so patient discharged home to finish course of Decadron. CKD3b: Cr mildly increased from baseline at 1.92. Remained around this level throughout admission. Pancytopenia: Patient has know anemia secondary to CKD, as well as thrombocytopenia. WCC also noted to be decreased. Likely overall pancytopenia secondary to Covid-19 infection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
History of Barrett's esophagus Dyslipidemia Anemia due to stage 3b chronic kidney disease (HCC) Idiopathic chronic gout of multiple sites without tophus Primary insomnia Moderate COPD (chronic obstructive pulmonary disease) (HCC) Hx of asbestos exposure Mycobacterium avium complex (HCC) History of bladder cancer Nocturnal hypoxemia CAD s/p CABG x 4 in 1999 without angina pectoris Stage 3b chronic kidney disease (HCC) OSA on CPAP Lung nodule Thrombocytopenia (HCC) Chronic fatigue
Andere Medikamente
allopurinol (ZYLOPRIM) 100 MG tablet aspirin 325 MG tablet atorvastatin (LIPITOR) 20 MG tablet Calcium Carbonate-Vitamin D (CALCIUM + D PO) dexamethasone (DECADRON) 6 MG tablet fish oil-omega-3 fatty acids 1000 MG capsule LORazepam (A
Allergien
Lipitor [Hmg-coa-r Inhibitors]Myalgia MorphineOther NiacinGout Nitrates, Organic [Organic Nitrates]Headache
Vorherige Impfungen
-

VAERS 1831616

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34yn4

schwer
Staat
OH
Alter
15,0
Geschlecht
M
Eingang
30.10.2021
Impfdatum
27.10.2021
Beginn
27.10.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Loss of consciousness

Symptomtext

Patient passed out in store about 1 hour after his vaccines. Patient was assessed by EMS and it was determined patient had only eaten noodles a few hours before vaccines and was light-headed due to not having eating in combination with vaccines. Patient left with parents on his own accord.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1815005

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

schwer
Staat
MI
Alter
42,0
Geschlecht
F
Eingang
25.10.2021
Impfdatum
22.10.2021
Beginn
22.10.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Loss of consciousness

Symptomtext

PATIENT PASSED OUT ABOUT 10 MINUTES AFTER RECEIVING VACCINATIONS. WITHIN A MINUTE OR SO SHE WAS UP AND DRINKING WATER. REFUSED CARE FROM 911 STATED THAT SHE HAD NOT EATEN, HAD NO PROBLEM WITH FIRST 2 DOSES OF PFIZER COVID19 VACCINE. PATIENT WAS MONITORED FOR ANOTHER 15 MINUTES BEFORE LEAVING. SAID SHE WAS FEELING MUCH BETTER

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
UNKNOWN
Andere Medikamente
UNKNOWN
Allergien
UNKNOWN
Vorherige Impfungen
-

VAERS 1663421

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

schwer
Staat
PA
Alter
12,0
Geschlecht
F
Eingang
01.09.2021
Impfdatum
28.08.2021
Beginn
28.08.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Syncope

Symptomtext

SYNCOPE

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1587416

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

schwer
Staat
NJ
Alter
35,0
Geschlecht
F
Eingang
19.08.2021
Impfdatum
19.08.2021
Beginn
19.08.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

PT DEVELOPED SYNCOPE AFTER GETTING HER FLU SHOT. PT WAS PLACED ON THE FLOOR AND FEET WERE ELEVATED. EMS CALLED. PT GOT BETTER AND REFUSED EMS. PT LEFT ON HER OWN WITH HER HUSBAND.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NA
Vorgeschichte
UNDER ACTIVE THYROID
Andere Medikamente
SYNTHROID 75MCG, VITAMIN D OTC
Allergien
NA
Vorherige Impfungen
FLU SHOT 3 YEARS AGO

VAERS 2473499

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge 34YN4

moderat
Staat
MI
Alter
74,0
Geschlecht
F
Eingang
10.10.2022
Impfdatum
04.11.2021
Beginn
29.09.2022
Tage bis Beginn
329,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Aortic valve incompetence Brain natriuretic peptide increased COVID-19 Cardiac failure acute Cardiac failure congestive Chest X-ray abnormal Condition aggravated Cough Dyspnoea Echocardiogram abnormal Hypoxia Left ventricular failure Lung infiltration Mitral valve incompetence Polyuria SARS-CoV-2 test positive

Symptomtext

Discharge Provider: Primary Care Provider: Admission Date: 9/29/2022 Discharge Date: Oct 1, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic combined systolic and diastolic CHF (congestive heart failure) (HCC) [I50.43] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 75 year old female with PMHx of chronic systolic CHF, HTN, CKD3, CAD, A-fib who presented to the hospital with shortness of breath and cough. She was found to be COVID-19 positive in the ER and had hypoxia. Patient had a CXR showing bilateral infiltrates. However the patient also had a significantly elevated BNP and was given IV lasix along with remdesivir and decadron. Patient improved quickly and was able to be weaned to room air off her O2. Patient diuresed well. She was afebrile after admission. Given her quick improvement (and symptoms only a few days) decadron was stopped as COVID-19 pneumonia was unlikely. Patient was kept and given 3 days of IV remdesivir. Patient was feeling much better at the time of discharge, she was breathing well on room air with no shortness of breath or cough, no fever. Patient was then considered stable for discharge home. Patient was instructed on signs and symptoms of when to return to the ER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
2,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
HTN (hypertension), benign Edema extremities Hypothyroidism due to acquired atrophy of thyroid Glaucoma Sensorineural hearing loss Macular degeneration, wet (HCC) Breast mass, right At risk for injury from chemotherapy History of radiation exposure Non-ischemic cardiomyopathy, EF 35% s/p CRT-D (chemo vs other) Atrial fibrillation (HCC) Acute on chronic combined systolic and diastolic heart failure (HCC) History of breast cancer GERD (gastroesophageal reflux disease) Enlarged lymph node, subcarinal seen on CT, 14 mm Pulmonary nodules Nausea Mood insomnia (HCC) Advance care planning Atrial flutter (HCC) Atrial flutter/AF with rapid ventricular response (HCC) Complete heart block (HCC) MR (mitral regurgitation), mild/mod Echo 6/2022 Nonrheumatic aortic valve insufficiency, mild/mod Echo 6/2022 Coronary artery disease involving native coronary artery of native heart without angina pectoris Biventricular implantable cardioverter-defibrillator (ICD) in situ Chronic combined systolic and diastolic heart failure (HCC) Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia (HCC)
Andere Medikamente
amiodarone (PACERONE) 200 MG tablet apixaban (ELIQUIS) 5 MG tablet aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 40 MG tablet calcium-vitamin D (CALCIUM 600+D) 600-200 MG-UNIT TABS per tablet dapagliflozin (FARXIGA) 10 MG TABS tablet
Allergien
ThimerosalSwelling Ceclor [Cefaclor]Hives Arimidex [Anastrozole]Other Brinzolamide Dye-contrastHives Netarsudil Shellfish Allergy
Vorherige Impfungen
-

VAERS 2412342

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) · Charge 34YN4

moderat
Staat
MI
Alter
64,0
Geschlecht
F
Eingang
16.08.2022
Impfdatum
06.10.2021
Beginn
13.08.2022
Tage bis Beginn
311,0
Dosis
N/A
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Blood potassium decreased COVID-19 Condition aggravated Diarrhoea Hypokalaemia Laboratory test Nausea Palpitations SARS-CoV-2 test positive Vomiting

Symptomtext

Discharge Provider: Private MD Primary Care Provider at Discharge: Private MD Admission Date: 8/13/2022 Discharge Date: 8/13/2022 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: Patient is a 65 y.o. female who presented to local Hospital as a transfer from ED for hypokalemia. Patient initially presented to emergency department for nausea, vomiting, diarrhea, and palpitations. Symptoms began 08/09/2022, and she took a home COVID test which was positive on 08/11/2022. Patient has history of low potassium and experiencing palpitations. In the emergency department she was found to have hypokalemia at 2.8, and intractable nausea. She was given potassium replacement, Zofran, IV fluids and sent to hospital for observation. On the general floor, patient had full resolution of nausea, vomiting, and diarrhea. She tolerated normal breakfast without difficulty. She did not have return of palpitations and repeat lab work showed resolution of hypokalemia. Patient was considered medically and vitally stable for discharge home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
1,0
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Tendonitis of wrist, right Elevated lipase Dehydration Osteoarthritis of right knee History of abdominoplasty Aspiration pneumonia of lower lobe, unspecified aspiration pneumonia type, unspecified laterality (HCC)
Andere Medikamente
acetaminophen (TYLENOL) 500 MG tablet amLODIPine (NORVASC) 5 MG tablet escitalopram (LEXAPRO) 10 MG tablet hydroCHLOROthiazide (HYDRODIURIL) 25 MG tablet levothyroxine (SYNTHROID) 50 MCG tablet ondansetron (ZOFRAN) 4 MG tablet potassium chl
Allergien
Vesicare [Solifenacin] Nitrofurantoin MacrocrystalHives
Vorherige Impfungen
-

VAERS 1764989

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

moderat
Staat
PA
Alter
56,0
Geschlecht
F
Eingang
06.10.2021
Impfdatum
23.09.2021
Beginn
23.09.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Extra dose administered Neuralgia Paraesthesia

Symptomtext

Patient states she has been experiencing significant neuropathic pain in unilateral left arm after receiving Pfizer vaccine. Pain is described as burning and tingling extending from site of vaccination at the deltoid to the tips of the fingers on the left arm. Pain was not present for this patient prior to receiving 3rd dose booster vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Consultation with specialist (neurologist)
Aktuelle Erkrankungen
-
Vorgeschichte
Multiple sclerosis
Andere Medikamente
duloxetine 30mg, lisinopril/hctz 20-12.5mg, baclofen 20mg, oxybutynin ER 5mg, pramipexole 0.125mg, gabapentin 300mg, diazepam 5mg, myrbetriq ER 25mg, kesimpta (specialty)
Allergien
No known drug allergies
Vorherige Impfungen
-

VAERS 1637011

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

moderat
Staat
MD
Alter
63,0
Geschlecht
F
Eingang
26.08.2021
Impfdatum
16.08.2021
Beginn
17.08.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chest discomfort Chest pain Chills Fatigue Headache Pyrexia

Symptomtext

Patient experienced a severe chest tightness a day after providing the vaccinations. Patient describe it as she was able to breathe but the tightness was very painful as she though twice about calling emergency number. She got headache, feverish and chills. She felt tired/exhausted and lasted for 4 days after the providing the vaccines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/a
Allergien
N/a
Vorherige Impfungen
-

VAERS 2583503

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

mild
Staat
MN
Alter
60,0
Geschlecht
F
Eingang
17.02.2023
Impfdatum
12.10.2021
Beginn
-
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Magnetic resonance imaging

Symptomtext

Patient reports right should pain starting after the 2021 influenza vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
Patient has MRI
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Codeine
Vorherige Impfungen
-

VAERS 2367939

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (OTHER) · Charge 34YN4

mild
Staat
-
Alter
60,0
Geschlecht
F
Eingang
13.07.2022
Impfdatum
27.10.2021
Beginn
27.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Injection site erythema Injection site pain Injection site swelling

Symptomtext

reddness, pain and swelling at injection site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
received antibiotics
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2347613

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

mild
Staat
MI
Alter
61,0
Geschlecht
F
Eingang
01.07.2022
Impfdatum
23.09.2021
Beginn
14.10.2021
Tage bis Beginn
21,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Post-traumatic stress disorder

Symptomtext

3 weeks after vaccination developed bilateral achy hip pain. She did not present to healthcare provider at that time. She had trouble walking due to pain. Slowly resolved over the course of 2 months

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No known illnesses at time of vaccination or one month prior
Vorgeschichte
Sleep Apnea, IBS, Borderline Personality Disorder, PTSD
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 1944189

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

mild
Staat
-
Alter
32,0
Geschlecht
F
Eingang
13.12.2021
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Headache Nausea Pyrexia Vomiting

Symptomtext

Thirty minutes after receiving vaccine, associate became nauseous and had a headache. She progressed to vomiting and fever of 102. This continued for several days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1870649

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

mild
Staat
NJ
Alter
51,0
Geschlecht
F
Eingang
15.11.2021
Impfdatum
06.11.2021
Beginn
06.11.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity

Symptomtext

PATIENT COMPLAINING OF PAIN IN THE ARM NOT GOING AWAY EVEN WITH MEDICATION 10 DAYS LATER.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1795381

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

mild
Staat
NJ
Alter
41,0
Geschlecht
F
Eingang
18.10.2021
Impfdatum
18.10.2021
Beginn
18.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood pressure increased Erythema Head discomfort Malaise Vision blurred

Symptomtext

PATIENT WAS GIVEN HER FLU VACCINE IN HER LEFT ARM AT 2PM. A FEW MINUTES LATER SHE CALLED ME AND TOLD ME SHE WASN'T FEELING WELL. HER NECK AND SCALP BECAME RED. EYES WERE BLURRY. SHE FELT LIKE, "HER HEAD WAS GOING TO EXPLODE". BLOOD PRESSURE BECAME ELEVATED FROM HER NORMAL BP. CALLED 911. SHE STARTED TO FEEL BETTER BEFORE 911 CAME. SHE WENT TO GET CHECKED OUT AT HOSPITAL.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1788359

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

mild
Staat
NY
Alter
4,0
Geschlecht
F
Eingang
15.10.2021
Impfdatum
15.10.2021
Beginn
15.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Swelling face

Symptomtext

Patient woke this morning with left sided facial swelling and rash under her arms and groin area.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1731933

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

mild
Staat
MI
Alter
64,0
Geschlecht
F
Eingang
24.09.2021
Impfdatum
21.09.2021
Beginn
21.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Pruritus Rash erythematous

Symptomtext

RED RASH WITH ITCHING ON FACE (EAR, EYE, NOSE), THROAT/NECK, CHEST, B/L ARMS AND LEGS. NO WEEPING/OPEN SORES, NOT PAINFUL JUST ITCHY. NO SHORTNESS OF BREATH. PT STATES ONSET ABOUT 1HR AFTER ADMINISTRATION OF VACCINE WITH SYMPTOMS SPREADING/WORSENING EACH DAY. PT SOUGHT MEDICAL ATTENTION AND RECEIVED PRESCRIPTION FOR PREDNISONE 9/24/21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
PT SOUGHT MEDICAL ATTENTION AND RECEIVED PRESCRIPTION FOR PREDNISONE 9/24/21
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 1624281

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

mild
Staat
PA
Alter
20,0
Geschlecht
F
Eingang
23.08.2021
Impfdatum
23.08.2021
Beginn
23.08.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Flushing Urticaria

Symptomtext

several hours post vaccine patient is experiencing hives on the trunk of her body and redness and flushing of her face. Her temperature at home was 99.6 degrees but when we rechecked it was 98.6 here at the pharmacy at the time she was lodging her complaint

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
had severe reaction to Prevnar in her youth
Vorherige Impfungen
-

VAERS 1801220

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34yn4

gering
Staat
IA
Alter
59,0
Geschlecht
F
Eingang
20.10.2021
Impfdatum
05.10.2021
Beginn
05.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products

Symptomtext

Patient received a Pfizer Covid booster. Their first 2 vaccines were Moderna.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1798363

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

gering
Staat
IA
Alter
0,2
Geschlecht
F
Eingang
19.10.2021
Impfdatum
15.10.2021
Beginn
15.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age Wrong product administered

Symptomtext

Patient was given Fluarix instead of Pediarix at the time of the event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 1787720

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 34yn4

gering
Staat
DE
Alter
39,0
Geschlecht
F
Eingang
15.10.2021
Impfdatum
04.10.2021
Beginn
04.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental exposure to product Accidental underdose Needle issue Syringe issue Underdose

Symptomtext

Underdose due to vaccine leakage; dose dripped over the patients arm; Inadvertent exposure to vaccine; This case was reported by a nurseand described the occurrence of accidental underdose in a 39-year-old female patient who received Flu Seasonal QIV Dresden (Fluarix Quadrivalent 2021-2022 season) (batch number 34yn4, expiry date 30th June 2022) for prophylaxis. Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis. On 4th October 2021, the patient received Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device. On 4th October 2021, unknown after receiving Fluarix Quadrivalent 2021-2022 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced accidental underdose, exposure via skin contact and inadvertent exposure to vaccine. On an unknown date, the outcome of the accidental underdose, exposure via skin contact and inadvertent exposure to vaccine were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details provided as follows: Nurse reported that the patient received underdose of the vaccine due to vaccine leakage, which led to accidental underdose. The reporter claimed that the needle was not properly attached to the prefilled syringe. They were not sure how much of the vaccine was administrated but claimed most of the dose dripped to the floor and the patients arm, which led to exposure via skin contact and inadvertent exposure to vaccine. No further events were reported. The reporter consent to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental exposure to product
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1759563

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34yn4

gering
Staat
MI
Alter
38,0
Geschlecht
M
Eingang
04.10.2021
Impfdatum
17.09.2021
Beginn
17.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administration error

Symptomtext

There wasn't actually an adverse event but I didn't see an option for a form for an administration error. We had only processed one of his 2 shots through the computer system so at first it seemed like he had gotten an extra vaccine. However we discovered he had wanted both vaccines and we just hadn't processed the flu shot through the computer. I am sorry if this isn't something that needs to be reported to you but my boss asked me to.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No listed illnesses.
Vorgeschichte
No listed chronic or long-standing health conditions.
Andere Medikamente
No listed medications.
Allergien
No listed allergies.
Vorherige Impfungen
-

VAERS 1759102

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

gering
Staat
MN
Alter
12,0
Geschlecht
F
Eingang
04.10.2021
Impfdatum
03.10.2021
Beginn
03.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect product formulation administered No adverse event

Symptomtext

Patient received the influenza vaccine instead of the COVID vaccine. No adverse events were documented.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect product formulation administered
Hospital-Tage
-
Labordaten
N/A.
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1758789

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34yn4

gering
Staat
IA
Alter
77,0
Geschlecht
M
Eingang
04.10.2021
Impfdatum
01.10.2021
Beginn
01.10.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered No adverse event

Symptomtext

Sub-therapeutic dose: Patient should of received a High Dose Varriation. No adverse event reported

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/a
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 1750431

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34YN4

gering
Staat
OH
Alter
29,0
Geschlecht
F
Eingang
30.09.2021
Impfdatum
30.09.2021
Beginn
30.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injury associated with device

Symptomtext

Vaccination was successful. Immediately afterwards I engaged the needle guard. The guard did not cover the tip of the needle and I jabbed my thumb.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injury associated with device
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1719518

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge 34yn4

gering
Staat
MN
Alter
65,0
Geschlecht
F
Eingang
21.09.2021
Impfdatum
18.09.2021
Beginn
18.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Wrong product administered

Symptomtext

Patient received the fluarix rather than the age recommended fluad.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None
Vorgeschichte
None.
Andere Medikamente
Unknown.
Allergien
NKDA
Vorherige Impfungen
-